Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system.
about
Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumorsAutocrine growth induced by the insulin-related factor in the insulin-independent teratoma cell line 1246-3A.Establishment of an interleukin-5-dependent subclone from an interleukin-3-dependent murine hemopoietic progenitor cell line, LyD9, and its malignant transformation by autocrine secretion of interleukin-5Synthesis and secretion of platelet-derived growth factor by human breast cancer cell linesTransformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene.Growth factor(s) produced during infection with an adenovirus variant stimulates proliferation of nonestablished epithelial cells.Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.Production of platelet-derived growth factorlike protein by rat mesangial cells in cultureLowering extracellular Na+ concentration releases autocrine growth factors from renal epithelial cellsGrowth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity.A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agentsAffinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survivalPolyomavirus middle tumor antigen increases responsiveness to growth factors.Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potentialThe viral Ki-ras gene must be expressed in the G2 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium.Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.Increased secretion of type beta transforming growth factor accompanies viral transformation of cellsUse of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.Epidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Theilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus.Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factorCharacterization of G1 transit induced by the mitogenic-oncogenic viral Ki-ras gene product.New rat cell line that is highly susceptible to transformation by several oncogenesAnti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell lineIsolation of tumor-secreted products from human carcinoma cells maintained in a defined protein-free medium.Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.Cultured endothelial cells produce a platelet-derived growth factor-like protein.Type beta transforming growth factor: a bifunctional regulator of cellular growthThe role of growth factors in normal and neoplastic haemopoiesis.Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.Prostatic adenocarcinoma. Carcinogenesis and growth.Growth factors in cancer and their relationship to oncogenes.Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptorRas-inducible immortalized fibroblasts: focus formation without cell cycle deregulation.Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes.Isolation of an autocrine growth factor from hepatoma HTC-SR cells.The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.
P2860
Q24339400-426C933F-9BB9-4463-8528-CC9888547C95Q33639503-FEF5C790-2930-49B4-A55E-62091C6C5B37Q33920201-5D8410BC-007C-4859-B3FA-C84D9C9973D1Q34339034-6320260C-836B-4231-879D-D042918894DEQ34600421-F752F097-C524-4E8A-BCDA-44954638F0AFQ34623462-620993A0-9BBB-473A-B771-F38CA669C8FCQ34751465-7D42BA3A-0EEE-49F9-BC28-7437DDDBE1A4Q35578330-C58C523D-44EB-4DB0-BB7C-0D892015B903Q35614532-A3122F68-7769-45AF-B37E-42BF228F5040Q36005156-F8314D74-2994-49A4-8AFA-247F9055FDA4Q36048261-1CDC482B-B76F-4DBA-8B25-9AA7469A1CAAQ36211634-DD639ED1-5FF3-4748-98B7-44B60B7534D1Q36257338-0B8F3905-AAD2-46C1-A1AE-B8DA68E9E942Q36320239-271ADD8C-4C4F-40A5-9706-8958697BEFDFQ36467797-51E9CACB-F711-423D-825A-A1F9B88E1041Q36689165-12CC5388-3DEE-4E6B-8D8B-E7506989D39BQ36792198-5ED346A9-71BC-4C10-A140-D765DF3B9F69Q36834029-A9340273-4CD5-4A0D-9979-60BD79E87C2BQ36874189-56CD9664-7D68-458F-A9D3-345970E4EE55Q36885110-A11E4AC7-850D-46E1-981F-E992D9C365E0Q36895520-EE219B15-0E97-43CF-9E03-42FAD1AC3778Q36910342-F1C7CE81-A1C3-49C1-B5F4-6D383E8FCFB8Q36910988-2F9E0729-C628-46F8-A752-053D5357AA8EQ36913032-0D38895C-FEBC-4C45-ABB4-7637034EC505Q36955891-30C4CC59-DE9E-48EB-A6AA-8E36490B463DQ37374782-EC3375B1-F078-4CB0-9215-FD17059120D4Q37530279-616A25BE-4744-46F1-B3E0-935FB9C930D4Q37536190-49E7FB13-3E36-4E47-9E36-A7ACFA52AC9EQ37607799-60DFBF71-8AD1-49C0-BC63-B6369B073BBDQ37672515-8940D092-EBBB-4D2E-A044-8CCA1A4282C9Q38185388-B67B2375-8866-4EB9-BB14-D966BEA633A3Q38304039-80C68DE6-15C2-4229-AEAC-CD1817510D9CQ38535009-20DC2B7B-7FEB-4D49-8580-6D2EFB124FBFQ39500167-A803627B-DE9B-4EFA-82E6-6DF0E13238A9Q40645752-4FCF37DC-FE9B-46ED-AD36-632724D2921FQ40667295-CD300794-7BCB-456E-BF05-85B53FD7F58FQ40722543-6C085A52-5EC9-4521-AD67-62B623D13E72Q41233268-769DDDAA-5479-42B6-9422-4668188960B5Q41271410-667F24B1-5FCE-45D1-992C-73F0B7CEDB53Q41670362-DCDCCA42-B6F5-4DE9-BB9D-80CCD5C4B73E
P2860
Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Transforming growth factor(s) ...... of serum: an autocrine system.
@ast
Transforming growth factor(s) ...... of serum: an autocrine system.
@en
type
label
Transforming growth factor(s) ...... of serum: an autocrine system.
@ast
Transforming growth factor(s) ...... of serum: an autocrine system.
@en
prefLabel
Transforming growth factor(s) ...... of serum: an autocrine system.
@ast
Transforming growth factor(s) ...... of serum: an autocrine system.
@en
P2860
P356
P1476
Transforming growth factor(s) ...... of serum: an autocrine system.
@en
P2093
P2860
P304
P356
10.1073/PNAS.79.2.485
P407
P577
1982-01-01T00:00:00Z